Inventor
WITTIG BURGHARDT
DE15 patents
⚠️ This page may combine multiple inventors who share the name “WITTIG BURGHARDT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MOLOGEN AG
6 patentsUS7635468B2Dec 22, 2009
Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine
MOLOGEN AG13 citations80
US8017591B2Sep 13, 2011
Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals
MOLOGEN AG13 citations77
US10006032B2Jun 26, 2018
Predictive biomarker for cancer therapy
MOLOGEN AG4 citations71
US7074772B2Jul 11, 2006
Design principle for the construction of expression constructs for gene therapy
MOLOGEN AG9 citations71
US10280424B2May 7, 2019
Covalently closed non-coding immunomodulatory DNA construct
MOLOGEN AG5 citations67
US7795406B2Sep 14, 2010
Agent for treating leishmania infections
MOLOGEN AG0 citations41
MOLOGEN FORSCHUNGS ENTWICKLUNG
2 patentsWITTIG BURGHARDT
2 patentsUS9212366B2Dec 15, 2015
Immune modulating oligonucleotides in connection with chemotherapeutic measures
WITTIG BURGHARDT9 citations80
US8669100B2Mar 11, 2014
DNA expression constructs encoding the Leishmania infantum antigens thiol-specific antioxidant protein and kinetoplastid membrane protein
WITTIG BURGHARDT0 citations39